China Proposes New Export Controls on AI, Biotech, and Solar Technologies
China is moving to expand its export control regime with a proposal to restrict overseas sales of roughly 40 technologies across three strategic sectors: artificial intelligence, biopharmaceuticals, and solar energy.
The proposed additions, announced by China's Ministry of Commerce, would broaden the scope of technologies already subject to export oversight. According to reports citing the proposal filed with the World Trade Organization, the new controls would cover AI-related technologies, biotech innovations including certain pharmaceutical manufacturing processes, and solar power components.
The move aligns with China's existing framework for controlling exports of sensitive technologies, which has previously included items such as rare earth processing techniques and certain semiconductor-related technologies. Officials have framed the expansion as a measure to protect national security and maintain strategic advantages in emerging technology fields.
The proposal comes as global competition intensifies in these technology sectors. China has been investing heavily in renewable energy infrastructure, particularly solar manufacturing, where it holds a dominant global market share. The country's biotech sector has also grown rapidly, with significant government backing for pharmaceutical and genetic research capabilities.
Technology companies and manufacturers operating across these sectors will need to monitor the implementation timeline and specific technical definitions once the proposal advances through the regulatory process.